Drug intelligence / Profile preview

Phenylethyl resorcinol

Development stage
Unknown
Lead developer
Symrise
Modality
Small Molecules
Administration
Topical
01

Overview

Phenylethyl resorcinol is a synthetic small molecule used primarily as a skin-lightening and antioxidant agent in cosmetic products. It acts as a potent inhibitor of tyrosinase—the key enzyme involved in melanin synthesis—by interacting with the copper centers of the enzyme and preventing the formation of dopaquinone, thereby reducing melanin production. This results in decreased pigmentation and lighter skin tone. Phenylethyl resorcinol also activates p44/42 MAPK signaling pathways leading to degradation of MITF protein (a transcription factor that increases tyrosinase expression), further inhibiting melanogenesis. In addition to its depigmenting effects, it exhibits strong antioxidant properties by scavenging free radicals generated by UV exposure and may have antidermatophytic activity against certain dermatophytes such as Microsporum gypseum. It is considered more potent than kojic acid for skin lightening and has better safety compared to hydroquinone[1][2][4][5][6].

Brand names
SymWhite 377SymWhite377SymWhite-377PRwhite
Other names
4-(1-phenylethyl)1,3-benzenediol
02

Targets

TYR (Tyrosinase)

Beyond the preview

Go deeper on Phenylethyl resorcinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phenylethyl resorcinol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call